Skip to main content
. 2021 Nov 16;21:2103. doi: 10.1186/s12889-021-12073-0

Table 2.

SARS-CoV-2 RNA, clinical disease and SARS-CoV-2 RNA antibodies (IgG) in the training and no-training arms. All data in numbers (%)

Total
(3,764 individuals)
Training arm
(1,896 individuals)
No-training arm
(1,868 individuals)
P-value4
SARS-CoV-2 RNA tests 3,016 (80.1) 1,682 (88.7) 1,334 (71.4)
Positive SARS-CoV-2 RNA 1 11 (0.05) 0 0.32
Covid-19 related hospital admissions 0 0 0
Non-Covid-19 related hospital admissions 6 (0.16) 4 (0.21) 2 (0.11) 0.42
 Cardiovascular 1 1 0
 Gastroenterology 1 0 1
 Surgery2 3 3 0
 Gynecology 1 0 1
Covid-19 outpatient contacts 0 0 0
Non-Covid-19 outpatient contacts 106 (2.8) 48 (2.5) 58 (3.1) 0.29
 Surgery2 46 20 26
 Gynecology 15 8 7
 Endocrinology/nephrology 12 6 6
 Cardiovascular 4 3 1
 Pulmonology 3 2 1
 Gastroenterology 6 0 6
 Dermatology 3 2 1
 Oncology 9 3 6
 Neurology 8 4 4
SARS-CoV-2 Antibody tests performed 2516 1404 1112
Positive SARS-CoV-2 antibodies 38 (1.53) 11 (0.83) 27 (2.43) 0.008

1Infection not related to training activity

2Surgery includes orthopedics and Ear-Nose-Throat

3Percentage of SARS-CoV-2 antibody tests performed

4All statistical test are performed on the intention-to-treat level